You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cystic fibrosis

OxyMask for delivering oxygen therapy

  • Medtech innovation briefing
  • Reference number: MIB160
  • Published:  27 September 2018

Download (PDF)
  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Specialist commentator comments
  • Specialist commentators
  • Development of this briefing

Regulatory information

OxyMask is a CE marked class IIa medical device.


Next page Equality considerations Previous page The technology
Back to top